Benitec Corp (BNTC) - Periode bali modal bisnis

Lambang korporat lan logo Benitec Corp (BNTC)

Exclusive FDA rights and robust patent protection create significant barriers to entry for new players in the niche. Benitec Biopharma Inc. (BNTC) leverages its innovative ddRNAi platform to develop one-time treatments for severe hereditary pathologies. However, a lack of profitability and dependence on capital render its financial position unstable. The market capitalization trend is fixed at -7.00, illustrating the current stage of clinical trials.

BNTC: Pangali P/E Benitec 04.07.2022 - 12.11.2026

Rincian analitis perusahaan Benitec (BNTC)

- rega saiki lan proyeksi nilai saham:
Kurs saham benitec.com|BNTC - Prakiraan konsensus analis
- indikator kapitalisasi pasar:
Kapitalisasi pasar Benitec Biopharma Inc.|BNTC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data kapitalisasi buku:
Rega Buku Saham Benitec Biopharma|BNTC - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku benitec.com|BNTC - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Benitec Biopharma Inc.|BNTC - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Benitec Corp|BNTC - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Benitec Biopharma Inc.|BNTC - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Benitec Biopharma|Likuiditas darurat benitec.com
- informasi bathi lan kelipatan valuasi:
BNTC - Bathi resik perusahaan|Bathi forward Benitec Biopharma Inc.|BNTC - Pangali P/E|Pangali mangsa ngarep rega marang bathi Benitec Biopharma Inc|BNTC - Pangali PEG|Pangali EV/EBITDA Benitec Biopharma Inc.|BNTC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Benitec Biopharma|BNTC - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan benitec.com|BNTC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Benitec Biopharma Inc.
Ringkesan analisis perusahaan:benitec.com
Produk mawa merek Benitec Corp

Benitec Biopharma Inc. (BNTC) focuses on developing innovative ddRNAi drugs for the therapy of rare genetic pathologies. Analyzing the Benitec Biopharma Inc. (BNTC) P/E chart, an investor sees the ratio of current market capitalization to net earnings per share. This multiple determines the cost of each dollar of earnings, allowing for an assessment of whether the asset is overvalued or undervalued. For a biopharmaceutical startup, such a metric serves as an indicator of market expectations regarding the future success of clinical trials.

Pesaing wigati

Pangali rega marang bathi TEM (Tempus AI Inc)|Pangali P/E QGEN|Periode bali modal bisnis Ionis Pharmaceuticals, Inc.|Repligen Corp. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik RNA (Avidity Corp)|CRISPR Therapeutics AG - Pangali P/E|Kapitalisasi marang bathi genedx.com|RARE: Pangali P/E|Koefisien rega marang bathi Beam Therapeutics Inc|Koefisien rega marang bathi SRPT|TWST: Nilai perusahaan marang bathi resik|Pangali P/E TXG|Rasio rega marang bathi NTLA (intelliatx.com)|Pangali P/E STOK (Stoke Therapeutics, Inc.)|Periode bali modal bisnis BioLife Solutions Inc (BLFS)|WVE - Rasio rega marang bathi|Kapitalisasi marang bathi Maze Therapeutics Corp|Sionna Therapeutics Inc (SION) - Rasio rega marang bathi|Kapitalisasi marang bathi resik PRME (primemedicine.com)|TSHA (Taysha Gene Therapies, Inc.) - Pangali P/E|QURE: Nilai perusahaan marang bathi resik|Pangali P/E MGTX|Pangali P/E REGENXBIO Corp (RGNX)|Rasio rega marang bathi Solid Biosciences Inc. SLDB|Nilai perusahaan marang bathi resik OCGN|PACB - Rasio rega marang bathi|Design Therapeutics Inc (DSGN) - Koefisien rega marang bathi|RCKT: Pangali P/E|4D Molecular Corp (FDMT) - Pangali P/E|Koefisien rega marang bathi LXEO|KRRO: Nilai perusahaan marang bathi resik|Pangali P/E EDIT|Periode bali modal bisnis Silence Therapeutics PLC|Rasio rega marang bathi ProQR Therapeutics PRQR|CDXS: Pangali rega marang bathi|Sangamo Therapeutics - Pangali P/E|Nautilus Biotechnology (NAUT) - Koefisien rega marang bathi|MGX (Metagenomi) - Koefisien rega marang bathi|DTIL - Periode bali modal bisnis|GBIO (Generation Bio Co) - Pangali P/E|Rasio rega marang bathi BOLD|Rasio rega marang bathi Exicure, Inc. (XCUR)|imunon.com - Pangali rega marang bathi|Phio Pharmaceuticals Corp. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik MBIO (Mustang Bio Inc)|TransCode - Pangali P/E|Bionano Genomics, Inc. (BNGO) - Koefisien rega marang bathi|APDN: Pangali P/E|Pangali rega marang bathi BLUE|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd|Pangali rega marang bathi OMGA (Omega Therapeutics Inc)|Pangali P/E OMIC|Pangali P/E Regulus (RGLS)|Pangali P/E SYRS (Syros Pharmaceuticals)|telesisbio.com - Rasio rega marang bathi|TRACON Pharmaceuticals, Inc. - Pangali P/E|Kapitalisasi marang bathi Unity Biotechnology Inc.